<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04527913</url>
  </required_header>
  <id_info>
    <org_study_id>Periobrush</org_study_id>
    <nct_id>NCT04527913</nct_id>
  </id_info>
  <brief_title>Interdental Plaque Reduction and Periodontitis</brief_title>
  <official_title>Interdental Plaque Reduction After Use of Different Devices in Patients With Periodontitis: a Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pisa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pisa</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the efficacy of four different oral hygiene protocols involving adjunctive&#xD;
      interdental cleaning devices in periodontal patients in terms of plaque and gingival&#xD;
      inflammatory scores.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients included in the study will undergo a thorough clinical examination aiming at&#xD;
      collecting all the data desired: periodontal parameters of Probing Pocket Depth (PPD),&#xD;
      presence of recession of the gingival margin (Rec) and full mouth plaque score (FMPS) will be&#xD;
      recorded on six sites/tooth by a single calibrated examiner using a University of North&#xD;
      Carolina (UNC) 15-mm periodontal probe by a calibrated examiner blind to group allocation.&#xD;
&#xD;
      Gingival index (GI) and angulated bleeding score (AngBS) will be recorded at four&#xD;
      sites/tooth.&#xD;
&#xD;
      For GI the following scale will be used:&#xD;
&#xD;
      0 normal appearance of gingiva, no bleeding, no inflammation;&#xD;
&#xD;
        1. slight change and moderate edema with slight change in texture, no bleeding, mild&#xD;
           inflammation;&#xD;
&#xD;
        2. redness hypertrophy, or edema and glazing, bleeding on probing, moderate inflammation;&#xD;
&#xD;
        3. marked redness, hypertrophy, or edema, ulceration, spontaneous bleeding, severe&#xD;
           inflammation.&#xD;
&#xD;
      For AngBS the following scale will be used:&#xD;
&#xD;
      0: no bleeding;&#xD;
&#xD;
        1. bleeding upon probe stimulation;&#xD;
&#xD;
        2. spontaneous bleeding&#xD;
&#xD;
      Consequently, interdental plaque score (IPS), interdental gingival index (IGI), and&#xD;
      interdental angulated bleeding score (IAngBI) will be calculated.&#xD;
&#xD;
      Patients will be followed through a five-week period. The timepoints will be the following: T&#xD;
      -7 (oral hygiene instructions), T0 (professional supragingival scaling and polishing), T14,&#xD;
      T28.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2011</start_date>
  <completion_date type="Actual">August 2020</completion_date>
  <primary_completion_date type="Actual">June 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Single-centre randomized, parallel design, clinical trial with a five-week follow-up</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
    <masking_description>Center will enroll probands, assigning a unique study subject number and allocating an opaque randomization envelope.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>FMPS Full-mouth plaque score (FMPS)</measure>
    <time_frame>Measured at: Baseline, at 1 week, at 3 weeks, and at 5 weeks</time_frame>
    <description>Changes in FMPS, measured orally through clinical examination. Unit of measure: N</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pocket probing depth (PPD)</measure>
    <time_frame>Measured at Baseline and at 5 weeks</time_frame>
    <description>Changes in PPD, measured orally through clinical examination. Unit of measure: mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recession of the gingival margin (REC)</measure>
    <time_frame>Measured at Baseline and at 5 weeks</time_frame>
    <description>Changes in REC, measured orally through clinical examination. Unit of measure: mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical attachment level (CAL)</measure>
    <time_frame>Measured at Baseline and at 5 weeks</time_frame>
    <description>Changes in CAL, measured orally through clinical examination. Unit of measure: mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gingival Index (GI)</measure>
    <time_frame>Measured at: Baseline, at 1 week, at 3 weeks, and at 5 weeks</time_frame>
    <description>Changes in GI, measured orally through clinical examination. Unit of measure: scale from 0 (normal) to 3 (Marked redness, hypertrophy, or edema, ulceration)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Angulated bleeding score (AngBS)</measure>
    <time_frame>Measured at: Baseline, at 1 week, at 3 weeks, and at 5 weeks</time_frame>
    <description>Changes in AngBS, measured orally through clinical examination. Unit of measure: scale from 0 (no bleeding), 1 (bleeding upon probe stimulation) to 2 (spontaneous bleeding).</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Periodontitis</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15 patients receiving oral hygiene instructions as determined by their group allocation (use of manual toothbrush alone)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15 patients receiving oral hygiene instructions as determined by their group allocation (manual toothbrush plus dental floss)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test group 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15 patients receiving oral hygiene instructions as determined by their group allocation (manual toothbrush plus interdental brushes)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test group 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15 patients receiving oral hygiene instructions as determined by their group allocation (manual toothbrush plus rubber interdental picks)</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Interdental Oral Hygiene Instruction (Int-OHI)</intervention_name>
    <description>Int-OHI will be given focusing on the interdental device of the allocated group for each patient and will be given only once at timepoint T0. No further formal Int-OH instructions will be given, unless specifically asked by the patient.&#xD;
Int-OHI will be delivered by trained dental hygienist/periodontist.</description>
    <arm_group_label>Test group 1</arm_group_label>
    <arm_group_label>Test group 2</arm_group_label>
    <arm_group_label>Test group 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>One session of professional supragingival scaling and polishing</intervention_name>
    <description>A session of professional supragingival scaling and polishing: instrumentation will be performed by a trained dental hygienist/periodontist with great care in performing exclusively coronal maneuver. No instrumentation or exploring of the gingival crevice/ sulcus will be performed.</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Test group 1</arm_group_label>
    <arm_group_label>Test group 2</arm_group_label>
    <arm_group_label>Test group 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Oral Hygiene Instruction (OHI)</intervention_name>
    <description>OHI will be given focusing on manual toothbrushing and will be given only once at timepoint T0. No further formal OH instructions will be given, unless specifically asked by the patient.&#xD;
OHI will be delivered by trained dental hygienist/periodontist.</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Test group 1</arm_group_label>
    <arm_group_label>Test group 2</arm_group_label>
    <arm_group_label>Test group 3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  males or females of age range between 18 and 70 years,&#xD;
&#xD;
          -  good health status,&#xD;
&#xD;
          -  presence of at least 20 natural teeth&#xD;
&#xD;
          -  residual periodontal pockets with PPDâ‰¥4mm, in need of specific oral hygiene regimen.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy or breast-feeding,&#xD;
&#xD;
          -  indication to antibiotic therapy prior to treatment,&#xD;
&#xD;
          -  chronic infections,&#xD;
&#xD;
          -  systemic diseases (including cardiovascular, pulmonary, cerebral, and metabolic&#xD;
             diseases),&#xD;
&#xD;
          -  not willing to give a consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital of Pisa</name>
      <address>
        <city>Pisa</city>
        <zip>56121</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 12, 2020</study_first_submitted>
  <study_first_submitted_qc>August 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 27, 2020</study_first_posted>
  <last_update_submitted>August 26, 2020</last_update_submitted>
  <last_update_submitted_qc>August 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pisa</investigator_affiliation>
    <investigator_full_name>Filippo Graziani, DDS MClinDent PhD</investigator_full_name>
    <investigator_title>Full Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

